Emerging therapeutic agents for advanced non-small cell lung cancer
Advanced non-small cell lung cancer (NSCLC) is the most common type of lung cancer, with a poor prognosis and no known cure. Survival time is often short because of limited treatment options. Recent advances i...
Source: Journal of Hematology and Oncology - Category: Hematology Authors: Ruqin Chen, Rami Manochakian, Lauren James, Abdel-Ghani Azzouqa, Huashan Shi, Yan Zhang, Yujie Zhao, Kexun Zhou and Yanyan Lou Tags: Review Source Type: research